Mechanism of anti-TNF therapy in inflammatory bowel disease
TNF is a cell signaling protein that plays a significant role in inflammatory bowel disease (IBS). Alon Levin investigates the mechanism of action of therapy that uses TNF inhibitors to treat IBS. The aim is to confirm the in vitro findings in vivo mouse models of IBS and to develop methods to enhance the therapeutic effect of anti-TNF.
A.D. Levin: Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease. Towards improving Efficacy of Anti-TNF Therapy.
Prof. G.R. van den Brink
Prof. G.R.A.M. D'Haens
Dr M.E. Wildenberg
Aula - Oude Lutherse kerk
Singel 411 | 1012 XM AmsterdamGo to detailpage
This event is open to the public.